after the company said it received final approval from the US drug regulator for its Tizanidine tablets. The announcement was made during trading... ...http://www.business-standard.com/article/news-cm/cadila-healthcare-gains-after-usfda-approval-for-drug-118031300361_1.html
Investors turn their attention to export-driven sectors, experts tell Krishna Kant. Illustration: Uttam Ghosh After betting on the domestic... ...http://www.rediff.com/money/report/can-these-stocks-shine-amid-market-gloom/20180308.htm
Posted by Equitymaster Launched a mere 8 years ago, Axis Long Term Equity Fund raced to the forefront of tax-saving schemes in just a few years of... ...http://feeds.equitymaster.com/~r/TheOutsideView/~3/gC2rOz_m37s/detail.asp
Posted by Equitymaster After opening the day on a positive note, stock markets in India have continued their momentum and are presently trading in... ...http://www.equitymaster.com/tm/tm.asp?date=2/12/2018&title=Indian-Indices-Continue-Momentum-Healthcare-Stocks-Witness-Buying
stock is quoting at Rs 424.1, up 3% on the day as on 12:54 IST on the NSE. Cadila Healthcare Ltd is up 13.65% in last one year as compared to a... ...http://www.business-standard.com/article/news-cm/cadila-healthcare-ltd-is-up-for-a-third-straight-session-today-118021200361_1.html
The company was formed way back in...